$GERN News

Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia

Geron Q2 2026 Earnings Call: Complete Transcript

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands

Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands

Geron to Present at Upcoming Investor Conferences

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corp.: Management's Plan Taking Shape As Competition Heats Up In Myelofibrosis

Geron (GERN) Stock Looks Reasonable On Sales But Weak On Returns

Geron (GERN) Back In Focus As Fresh Guidance And Earnings Test Its Undervalued Narrative

Geron (GERN) Q2 2026 Earnings Call Transcript

Geron Corp (GERN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Geron Corporation Q2 2026 Earnings Call Summary

Geron Q2 Earnings Call Highlights

Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates

Geron (NASDAQ:GERN) Falls After Mixed Q2 Results; Revenue Beats but Loss Wider Than Expected

Geron Corporation (GERN) Q2 2026 Earnings Call Transcript

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights